MAPK3 and Parkinson disease: Both orthostatic agonist and PAM of mGluR II/III modulated caspase-3 activation reduced necrotic nuclei and up-regulated pro-survival ERK1/2 phosphorylation MPP+-treated differentiated SH-SY5Y dopaminergic cells of a PD model.